Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Shares Outstanding
Others
Ratios

Syndax Pharmaceuticals (SNDX) Operating Expenses (2016 - 2020)

Historic Operating Expenses for Syndax Pharmaceuticals (SNDX) over the last 6 years, with Q4 2020 value amounting to $20.2 million.

  • Syndax Pharmaceuticals' Operating Expenses rose 3877.27% to $20.2 million in Q4 2020 from the same period last year, while for Sep 2021 it was $20.2 million, marking a year-over-year decrease of 6991.9%. This contributed to the annual value of $363.4 million for FY2024, which is 5801.07% up from last year.
  • Per Syndax Pharmaceuticals' latest filing, its Operating Expenses stood at $20.2 million for Q4 2020, which was up 3877.27% from $20.2 million recorded in Q3 2020.
  • In the past 5 years, Syndax Pharmaceuticals' Operating Expenses ranged from a high of $20.7 million in Q4 2017 and a low of $8.9 million during Q2 2016
  • Moreover, its 5-year median value for Operating Expenses was $15.6 million (2016), whereas its average is $15.9 million.
  • Its Operating Expenses has fluctuated over the past 5 years, first surged by 15219.86% in 2016, then crashed by 2601.33% in 2019.
  • Over the past 5 years, Syndax Pharmaceuticals' Operating Expenses (Quarter) stood at $11.4 million in 2016, then skyrocketed by 80.69% to $20.7 million in 2017, then dropped by 4.69% to $19.7 million in 2018, then dropped by 26.01% to $14.6 million in 2019, then soared by 38.77% to $20.2 million in 2020.
  • Its Operating Expenses stands at $20.2 million for Q4 2020, versus $20.2 million for Q3 2020 and $17.0 million for Q2 2020.